Japan's government is preparing legislation to prohibit the use of gene-editing technology like CRISPR on human embryos intended for birth, joining a growing number of countries drawing ethical lines around human genetic modification.
The proposed ban would make it illegal to use technologies like CRISPR-Cas9 to edit the genes of embryos that will be implanted and brought to term, effectively blocking the creation of so-called "designer babies" with selected genetic traits.
While US regulation lags, other advanced economies are making clear policy choices about genetic engineering boundaries. The technology exists—the question is whether society will allow its use.
CRISPR technology has revolutionized biological research by making precise genetic edits relatively simple and affordable. Scientists can now modify DNA with unprecedented accuracy, opening doors to treating genetic diseases, improving crops, and fundamentally altering living organisms.
But when it comes to editing human embryos, most countries have decided that just because we can doesn't mean we should. The concerns are both practical and philosophical: off-target genetic changes could have unforeseen consequences, edited genes would be passed to future generations, and society hasn't agreed on which traits should be "designed" in or out.
Japan's move puts it alongside countries like Germany, France, and Canada that have banned or heavily restricted germline editing. The United States, by contrast, has no federal law explicitly banning the practice, relying instead on FDA regulations that prohibit clinical trials without approval.
The reality is that the technology for genetic modification of human embryos already exists and has been demonstrated. In 2018, Chinese researcher He Jiankui shocked the world by announcing he had created the first gene-edited babies, leading to his imprisonment in China and global condemnation.
Japan's legislation is a recognition that technological capability doesn't equal social readiness. By drawing a clear legal line, Japan is making a choice about what kind of genetic future it wants—and doesn't want—to enable.
